Metformin: Is it a Truly Magic Drug?

Authors: Mervat M El-Eshmawy*

DOI: 10.23880/doij-16000177

Volume 3, Issue 2

Abstract

Metformin has been the mainstay of therapy for type 2 diabetes (T2D) for many years; it has been used for its glucose-lowering effect since 1957 in Europe and 1995 in USA. Besides being highly effective in improving glycemic control, metformin has also a low risk of hypoglycemia. Metformin remains at the head of management algorithms for T2D, either as mono therapy or in combination with sulfonylureas, thiazolidinediones and insulin.

Keywords: Metformin; Therapy

View PDF